Even a routine blood test may come with an overnight fasting requirement. Many medical practices still ask patients to go without food for 8–12 hours before blood is drawn. While the protocol was ...

A controversial blood test aimed at detecting multiple cancers was backed by a U.S. Food and Drug Administration panel this week. On Wednesday, Sept. 23, the FDA's Molecular and Clinical Genetics ...

A U.S. Food and Drug Administration advisory panel voted in favor of recommending that the agency approve a blood test for multiple cancers on Wednesday. The assay, called the Galleri test, is ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

On August 24, 2026, the U.S. FDA cleared a new single-biomarker blood test to help doctors detect signs of Alzheimer’s disease. The test helps doctors determine both rule-in (positive result) and rule ...

The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time such a blood test has been approved in less than two years. Roche announced ...

Washington — A blood test may predict if apparently healthy older adults are likely to develop Alzheimer's symptoms in the next five or 10 years, researchers reported Wednesday. That information could ...

New studies are shedding light on how the tests could eventually transform treatment. By Dana G. Smith and Pam Belluck Research presented this week at the Alzheimer’s Association International ...

Cognitively healthy older adults with high levels of a biomarker called p-tau217 in their blood had an estimated 38% greater chance of developing early signs of dementia over five years, a new study ...

Blood tests on the horizon, and under federal regulatory view, may be about to transform cancer care — and survival. The Food and Drug Administration has been evaluating a blood test called Galleri ...

For years, doctors relied only on written memory tests, invasive spinal taps and expensive imaging to diagnose Alzheimer’s disease. Now, two Food and Drug Administration-cleared blood tests are ...

CHARLOTTE, N.C.--(BUSINESS WIRE)--Compass Precision, LLC (“Compass”), a Charlotte-based, manufacturer of custom precision metal components announced today that it has acquired Accu-Tool, LLC ...